Viking Therapeutics Research and Development Expenses 2014-2024 | VKTX
Viking Therapeutics research and development expenses for the twelve months ending September 30, 2024 were $0.091B, a 53.25% increase year-over-year.
- Viking Therapeutics annual research and development expenses for 2023 were $0.064B, a 17.65% increase from 2022.
- Viking Therapeutics annual research and development expenses for 2022 were $0.054B, a 20.57% increase from 2021.
- Viking Therapeutics annual research and development expenses for 2021 were $0.045B, a 40.87% increase from 2020.